Proteomic profiling implies mitochondrial dysfunction in tachycardia-induced heart failure.

[1]  A. Vlahou,et al.  Clinical proteomics: current techniques and potential applications in the elderly. , 2011, Maturitas.

[2]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[3]  C. Nediani,et al.  Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: from molecular mechanisms to therapeutic implications. , 2011, Antioxidants & redox signaling.

[4]  D. Brutsaert,et al.  Cardiac failure: quo vadis? , 2010, European journal of heart failure.

[5]  C. Hoppel,et al.  Mitochondria in heart failure. , 2010, Cardiovascular research.

[6]  M. Podgoreanu,et al.  Energetics and metabolism in the failing heart: important but poorly understood , 2010, Current opinion in clinical nutrition and metabolic care.

[7]  A. Knowlton,et al.  Mitochondria and heart failure: new insights into an energetic problem. , 2010, Minerva cardioangiologica.

[8]  D. Kass,et al.  Modulation of Mitochondrial Proteome and Improved Mitochondrial Function by Biventricular Pacing of Dyssynchronous Failing Hearts , 2010, Circulation. Cardiovascular genetics.

[9]  C. Des Rosiers,et al.  Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart. , 2010, Journal of molecular and cellular cardiology.

[10]  B. Weimer,et al.  Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. , 2010, Cardiovascular research.

[11]  S. Dhein,et al.  Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[12]  P. Amouyel,et al.  Proteomic analysis of left ventricular remodeling in an experimental model of heart failure. , 2008, Journal of proteome research.

[13]  Michael Böhm,et al.  Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 , 2008, European journal of heart failure.

[14]  Yen-Hung Lin,et al.  A proteomic study of the effects of ramipril on post‐infarction left ventricular remodelling in the rabbit , 2008, European journal of heart failure.

[15]  G. Cooper,et al.  Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats , 2008, Proteomics.

[16]  T. Kislinger,et al.  Proteomics‐based investigations of animal models of disease , 2008, Proteomics. Clinical applications.

[17]  J. Marín-García,et al.  Mitochondrial centrality in heart failure , 2008, Heart Failure Reviews.

[18]  C. Hengstenberg,et al.  Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP. , 2007, Cytokine.

[19]  K. Clarke,et al.  Mitochondria and heart failure , 2007, Current opinion in clinical nutrition and metabolic care.

[20]  Masahiro Fukuoka,et al.  Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine. , 2007, The Canadian journal of cardiology.

[21]  M. Horie,et al.  Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure. , 2006, Journal of cardiac failure.

[22]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[23]  D. Charlemagne,et al.  Annexins and Ca2+ handling in the heart. , 2005, Cardiovascular research.

[24]  A. Görg,et al.  Current two‐dimensional electrophoresis technology for proteomics , 2004, Proteomics.

[25]  M. Dunn,et al.  Proteomics of heart disease. , 2003, Human molecular genetics.

[26]  D. Driscoll,et al.  Myosin Light Chain Mutation Causes Autosomal Recessive Cardiomyopathy With Mid-Cavitary Hypertrophy and Restrictive Physiology , 2002, Circulation.

[27]  A. Luchner,et al.  Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction. , 2001, Cardiovascular research.

[28]  M. Redfield,et al.  Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[29]  A. Görg,et al.  The current state of two‐dimensional electrophoresis with immobilized pH gradients , 2000, Electrophoresis.

[30]  M. Dunn,et al.  Studying heart disease using the proteomic approach. , 2000, Drug discovery today.

[31]  M. Redfield,et al.  Augmented cardiac cardiotrophin-1 in experimental congestive heart failure. , 2000, Circulation.

[32]  P. Armstrong,et al.  Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure. , 1999, Cardiovascular research.

[33]  M. Redfield,et al.  Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. , 1998, American journal of physiology. Heart and circulatory physiology.

[34]  A. Samarel,et al.  Myosin heavy chain synthesis during the progression of chronic tachycardia induced heart failure in rabbits , 1998, Basic Research in Cardiology.

[35]  M. Redfield,et al.  Angiotensin II in the evolution of experimental heart failure. , 1996, Hypertension.

[36]  I. Rayment,et al.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle , 1996, Nature Genetics.

[37]  G. Dorn,et al.  Annexin VI overexpression targeted to heart alters cardiomyocyte function in transgenic mice. , 1996, The American journal of physiology.

[38]  G. Riegger,et al.  Experimental heart failure produced by rapid ventricular pacing in the dog. , 1995, Journal of cardiac failure.

[39]  G. Riegger,et al.  Characteristics and clinical relevance of animal models of heart failure. , 1995, Current opinion in cardiology.

[40]  F. Spinale,et al.  Left ventricular and myocyte structure and function following chronic ventricular tachycardia in rabbits , 1994, Basic Research in Cardiology.

[41]  R. Tunin,et al.  Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure. , 2006, Journal of molecular and cellular cardiology.

[42]  C. Solares,et al.  Tachycardia-induced cardiomyopathy. , 2003, The American journal of medicine.

[43]  M. Duchen,et al.  The FASEB Journal express article 10.1096/fj.01-0892fje. Published online February 12, 2002. , 2022 .